GLP-1 Weight Loss Treatment in Bangalore — Semaglutide & Tirzepatide

What Are GLP-1 Medications?

GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a class of medications that mimic the action of the naturally occurring GLP-1 hormone in your body. This hormone plays a crucial role in regulating appetite, blood sugar, and digestion. By activating GLP-1 receptors in the brain, stomach, and pancreas, these medications effectively reduce hunger, increase feelings of fullness, slow stomach emptying, and improve insulin secretion.

At EQUA in HSR Layout, Bangalore, we offer the full range of GLP-1 medications — Semaglutide, Tirzepatide, and Liraglutide — all prescribed and monitored by our DM-qualified endocrinologists. GLP-1 therapy represents the most significant advancement in obesity treatment in decades, offering weight loss results that rival bariatric surgery without the risks and recovery time of surgical procedures.

Am I Eligible for GLP-1 Treatment?

GLP-1 medications are prescribed for adults who meet specific medical criteria. At EQUA, our endocrinologists conduct a thorough assessment before recommending any treatment:

• BMI ≥ 30 (obese range) — eligible for GLP-1 therapy
• BMI 27–29.9 (overweight) with at least one weight-related condition: Type 2 Diabetes, PCOS, hypertension, high cholesterol, sleep apnoea, or fatty liver disease
• BMI ≥ 25 for Indian patients — lower thresholds apply due to higher metabolic risk at lower BMI in South Asian populations

Your assessment includes body composition analysis, metabolic blood panels (blood sugar, HbA1c, lipid profile, liver function), blood pressure, waist circumference, and a review of your medical history and previous weight loss attempts.

GLP-1 medications are NOT suitable if you: have a personal or family history of medullary thyroid carcinoma or MEN-2 syndrome, are pregnant or breastfeeding, have severe gastrointestinal disease, or have a history of pancreatitis. Our endocrinologists will discuss your individual risk profile during consultation.

GLP-1 Medications Available in Bangalore

Three GLP-1 medications are available in India for weight management. Each has different characteristics, and our endocrinologists will recommend the best option based on your medical profile:

GLP-1 Treatment Cost in Bangalore

We believe in transparent pricing. Here are the typical monthly costs at EQUA, including endocrinologist consultations, body composition tracking, and dose adjustments:

What’s included: All consultations with DM-qualified endocrinologists, dose titration, body composition analysis at baseline and follow-up, metabolic blood panels, and 24/7 WhatsApp support during treatment.

Why prices vary: Costs depend on the dose (starting doses are cheaper), the pharmacy, and whether you choose branded or biosimilar versions. We prescribe only verified, DCGI-approved medications — never grey-market or imported sources.

How GLP-1 Medications Work for Weight Loss

GLP-1 receptor agonists produce weight loss through multiple complementary mechanisms, making them far more effective than simple appetite suppressants of the past:

• Appetite Reduction: GLP-1 receptors in the hypothalamus are activated, significantly reducing hunger signals and food cravings. Patients report feeling less preoccupied with food and eating.
• Enhanced Satiety: The medications slow gastric emptying, meaning food stays in your stomach longer after meals. This creates a prolonged feeling of fullness and satisfaction with smaller portions.
• Improved Insulin Sensitivity: By improving how your body responds to insulin, GLP-1 medications reduce the fat-storage signals that drive weight gain, particularly around the abdomen.
• Reduced Food Reward: GLP-1 receptors in the brain's reward centers reduce the pleasurable response to high-calorie foods, naturally reducing cravings for sugary and fatty foods.

This multi-targeted approach is why GLP-1 medications achieve weight loss results that are 3-5 times greater than lifestyle modification alone.

Safety and Side Effects

GLP-1 medications are approved by the FDA, EMA, and DCGI (Drugs Controller General of India) for weight management. They have been studied extensively in large clinical trials involving tens of thousands of patients. Common side effects are generally mild and temporary:

• Nausea (most common, typically resolves within 2-4 weeks)
• Vomiting or diarrhea (less common, usually transient)
• Constipation
• Injection site reactions (redness, mild discomfort)

Serious side effects are rare but can include pancreatitis, gallbladder disease, and severe gastrointestinal events. These risks are minimized through proper patient selection, gradual dose titration, and regular monitoring by our endocrinologists.

GLP-1 medications are NOT suitable for everyone. Contraindications include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, and severe gastrointestinal disease. Our endocrinologists thoroughly evaluate your suitability before prescribing.

Drug Interactions & Precautions

GLP-1 medications can interact with other drugs. Always inform your endocrinologist about all medications you are taking:

• Insulin & sulfonylureas: May need dose reduction to avoid hypoglycaemia (low blood sugar). Our endocrinologists adjust doses carefully.
• Oral contraceptives: GLP-1 medications may delay stomach emptying, potentially reducing oral contraceptive absorption. Discuss alternative contraception with your doctor.
• Blood thinners (warfarin, DOACs): May require closer INR monitoring due to delayed stomach emptying affecting absorption.
• Other weight loss medications: Do not combine GLP-1 medications with other prescription weight loss drugs without medical supervision.

Pregnancy & breastfeeding: GLP-1 medications must be discontinued at least 2 months before a planned pregnancy. They are not recommended during breastfeeding. If you become or plan to become pregnant, contact your endocrinologist immediately.

How to Use GLP-1 Injections

GLP-1 medications are administered as a subcutaneous injection using a pre-filled pen. Our nursing team will demonstrate the technique at your first visit:

• Injection sites: Abdomen (2 inches from navel), thigh, or upper arm. Rotate sites weekly.
• Technique: Clean the site with an alcohol swab, pinch the skin, insert the needle at 90 degrees, and press the pen button. Hold for 10 seconds.
• Timing: Inject on the same day each week (for weekly medications) or at the same time daily (for Liraglutide). You can inject with or without food.
• Missed dose: If you miss a weekly dose, take it within 48 hours. If more than 48 hours have passed, skip the missed dose and resume your regular schedule. Do not double-dose.
• Storage: Store unopened pens in the refrigerator (2–8°C). Once opened, most pens can be kept at room temperature (below 30°C) for up to 28 days. Do not freeze.

What Happens When You Stop GLP-1 Medications?

Weight regain after stopping GLP-1 medications is common. Clinical studies show that most people regain 50–80% of lost weight within 1–5 years of discontinuation, because the hormonal adaptations that caused obesity in the first place persist.

This is why GLP-1 therapy is generally prescribed as a long-term treatment, not a short-term intervention — similar to how blood pressure or diabetes medications are continued indefinitely.

At EQUA, our approach focuses on:

• Combining medication with lifestyle modifications to build sustainable habits
• Gradual dose reduction (rather than abrupt stopping) when appropriate
• Ongoing body composition monitoring to catch early weight regain
• Maintenance programs that support long-term metabolic health

The goal is not just weight loss — it is sustained metabolic improvement. Learn why obesity is a chronic disease requiring long-term treatment →

Frequently Asked Questions